A detailed history of Rmb Capital Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Rmb Capital Management, LLC holds 8,616 shares of PCVX stock, worth $629,140. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,616
Previous 7,901 9.05%
Holding current value
$629,140
Previous $902,000 21.84%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$80.97 - $117.93 $57,893 - $84,319
715 Added 9.05%
8,616 $705,000
Q3 2024

Nov 06, 2024

BUY
$70.52 - $117.12 $557,178 - $925,365
7,901 New
7,901 $902,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $4.33B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.